Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Martin Kunz appointed new President and CEO of Concentric

The Board of Directors of Concentric AB has today appointed Martin Kunz as the new President and CEO. He will succeed David Woolley on March 1, 2022. Martin Kunz is a German citizen with a master's degree in mechanical engineering and business administration from Technical University of Kaiserslautern and has a longstanding international experience in leading regional and global businesses as well as commercial organizations in flow control and other OEM industries. Martin has worked out of multiple countries such as Germany, Spain, Mexico, France, the UK and Switzerland and accumulates

Talkpool calls for Decision Procedure in Bond Loans of SEK 24,000,000, ISIN SE0011311414, with proposals for adjustment in the bond terms

Talkpool AG (“Talkpool”) has an outstanding bond loan of SEK 24,000,000, named SE0011311414, (the “Bond Loan”). The issuer has had and is in ongoing dialogue with stakeholders regarding refinancing, and the sale of parts of the business. These have not yet been put in place, which is why the issuer is now calling on the creditors of the Bond Loan for a decision-making procedure with the following changes in the terms of the bond: • Extension of the Bond Loan from 31 December 2021 to 31 December 2022, with the option to repay on an ongoing basis • Opportunity to sell parts of the

Vyepti[®] (eptinezumab) approved by the EU Commission for the preventive treatment of migraine in adults

· Vyepti is the first intravenous (IV) treatment approved for migraine prevention in Europe · Vyepti is expected to be launched in the first European countries in the coming months Valby, Denmark, January 24, 2022 - H. Lundbeck A/S (Lundbeck) announced that the European Commission has granted marketing authorization for Vyepti® (eptinezumab) in the European Union (EU) for the prophylactic treatment of migraine in adults who have at least four migraine days per month. The approval follows the positive opinion on November 11[th], 2021 from the European Medicines Agency’s (EMA) Committee

DexTech Medical AB, Last day of trading in BTA

DexTech Medical AB (“DexTech” or the “Company”) hereby announces that the last day of trading in Paid Subscribed Shares (Sw. BTA) will be on 27 January 2022 and stop day will be on 31 January 2022. During December 2021, DexTech conducted a rights issue, which provided the Company approximately SEK 46.35 million before deduction of transaction related costs. The rights issue has now been registered with the Swedish Companies Registration Office (Sw. Bolagsverket) and the last day of trading in BTA will be on 27 January 2022 and stop day will be on 31 January 2022. The shares are estimated

ALEXANDRIA PANKKIIRILIIKE OYJ: ACQUISITION OF OWN SHARES 24.01.2022

ALEXANDRIA PANKKIIRILIIKE OYJ NOTIFICATION 24.01.2022 at 18:30 EET ALEXANDRIA PANKKIIRILIIKE OYJ: ACQUISITION OF OWN SHARES 24.01.2022 Date 24.01.2022Exchange transaction BuyShare class ALEXAmount 573Average price/share 8.4500 EURHighest price/share 8.4500 EURLowest price/share 8.4500 EURTotal price 4,841.85 EUR The shares held by Alexandria Pankkiiriliike Oyj on 24.01.2022: ALEX 51,541 On behalf of Alexandria Pankkiiriliike Oyj  Skandinaviska Enskilda Banken AB (Publ)

Initiation of a written procedure

SGL International A/S (the "Company") has instructed the agent for the Company's up to EUR 40,000,000 subordinated unsecured pik interest rate bonds with ISIN SE0016797625 (the "Bonds") to initiate a written procedure to request that bondholders vote in favour of a mandatory exchange of Bonds for new bonds that will be issued with Verdipapirsentralen ASA as central securities depository and registrar on terms and conditions that will otherwise mirror the terms and conditions of the Bonds. The notice to the written procedure is available on the Company's website (www.scangl.com) and on

Notice to the Extraordinary General Meeting of Loudspring Plc

Loudspring Plc Company Release                                       24 January 2022 at 18:00 (EET) Notice to the Extraordinary General Meeting of Loudspring Plc The Extraordinary General Meeting of Loudspring Plc will be held on 16 February 2022 at 10:00 (EET) Loudspring’s office, Fredrikinkatu 71 A, 00100 Helsinki, Finland. Shareholders and their proxy representatives can participate in the meeting and exercise their shareholder rights only by voting in advance and/or by making counterproposals and/or presenting questions in advance. Instructions for shareholders are presented

Nordic Nanovector ASA - Notice of extraordinary general meeting

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA, SOUTH AFRICA, NEW ZEALAND, JAPAN OR THE UNITED STATES, OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL Nordic Nanovector ASA - Notice of extraordinary general meeting Reference is made to the stock exchange announcements by Nordic Nanovector ASA ("Nordic Nanovector" or the "Company") on 19 January 2022 regarding the successfully completed private placement of 17,857,143

Flex LNG - Invitation to Q4 2021 presentation and webcast

Hamilton, BermudaJanuary 24, 2021 Flex LNG Ltd. (“Flex LNG” or the “Company”) will release its preliminary financial results for the fourth quarter of 2021 on Wednesday February 16, 2022 on or about 07:00 CET (1:00 a.m. EST). In connection with the earnings release, a webcast and conference call will be held at 15:00 CET (9:00 a.m. EST) the same day. In order to attend the webcast and/or conference call you may do one of the following: Attend by Webcast:Use to the follow link prior to the webcast: https://edge.media-server.com/mmc/p/42dfa2a2 

#22-29 Delisting of certain Loan Debenture from NGM

On January 24th, 2022 Ampla Kapitalandelsbevis1 with ISIN SE0006091880 will be delisted from NGM.For more details see attached files. For further information concerning this NGM notice please contact: Listing department on +46 8 566 390 20 or at listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded

Fourth quarter 2021 trading update

Aker BP will publish its financial report for the fourth quarter 2021 on Thursday 10 February 2022. The company issues this trading update to summarize its production and sales volumes and related topics for the quarter. Oil and gas production and sales Aker BP produced 207.0 thousand barrels of oil equivalents per day (mboepd) in the fourth quarter, while net volume sold amounted to 205.1 mboepd. Production was below average in the first half of the quarter due to project activities and various technical issues, but increased towards the end of the year with December volumes above

#22-28 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

Proposals of the Shareholders’ Nomination Board to Wärtsilä’s Annual General Meeting 2022

Wärtsilä Corporation, Stock exchange release, 24.1.2022 at 17:00 PM EETProposals of the Shareholders’ Nomination Board to Wärtsilä’s Annual General Meeting 2022 The Shareholders' Nomination Board of Wärtsilä Corporation presents the following proposals to the Annual General Meeting to be held on 3 March 2022. The proposals will be included in the notice to the Annual General Meeting to be published at a later date. Proposal on the composition of the Board of Directors The Shareholders' Nomination Board proposes that the number of Board members shall be eight. The Nomination

Bravida Norway acquires pipe company Langhus Rør AS and strengthens its position in end-to-end solutions in Follo

Bravida Norway is buying 100 percent of the shares in Langhus Rør AS and thereby strengthening its range of end-to-end solutions in Follo. The company has 14 employees and had sales of just over NOK 18.5 million in 2021.Langhus Rør was founded in 2010 and offers services relating to renovation, plumbing, heating, bathrooms, service and maintenance. The company operates in the Follo and Innlandet areas, mainly addressing the private sector, including residential and commercial buildings.   “The acquisition fits well with Bravida’s growth strategy and ambitions, and we are now

Buybacks of shares in Alfa Laval during week 3, 2022

During the period January 17 – January 21, 2022, Alfa Laval AB (publ) (LEI code: 549300UCKT2UK88AG251) has repurchased in total 92,849 own shares (ISIN: SE0000695876) as part of the share buyback program initiated by the Board of Directors in order to secure optimized capital structure.The share buybacks form part of the SEK 2 billion share buyback program, which Alfa Laval announced on April 27, 2021. The share buy-back program, which runs between April 28, 2021 and April 25, 2022, is being carried out in accordance with the EU Market Abuse Regulation (MAR) and the Commission Delegated

Metso Outotec to publish its Financial Statements Review for January-December 2021 on Thursday, February 10, 2022

Metso Outotec Corporation’s press release on January 24, 2022, at 4:00 p.m. EETMetso Outotec’s Financial Statements Review for January-December 2021 will be published on Thursday, February 10, 2022, at about 9:00 a.m. EET and can be found on the Metso Outotec website .  President and CEO Pekka Vauramo and CFO Eeva Sipilä will present the results in an audiocast and a conference call for analysts and investors on the same day at 1:00 p.m. EET.  The audiocast can be followedat the company’s website 

Buybacks of series B shares in AB Electrolux during week 03, 2022

Stockholm, Sweden, January 24, 2022 During the period January 17 – January 21, 2022 AB Electrolux (LEI code 549300Y3HHZB1ZGFPJ93) has repurchased in total 1,381,353 own series B shares (ISIN: SE0016589188) as part of the buyback program initiated by the Board of Directors in order to optimize the company’s capital structure.The share buybacks form part of the buyback program of a maximum of 9,369,172 series B shares for a total maximum amount of SEK 2,800 million, which AB Electrolux announced on October 27, 2021. The buyback program, which runs between October 28, 2021 – March 25, 2022,

Transactions in connection with share buyback programme

Company announcement 4/2022 On 4 January 2022, HusCompagniet A/S (“HusCompagniet”) launched a share buyback programme, as described in Company Announcement No. 1/2022. According to the programme, HusCompagniet will in the period from 4 January 2022 to 31 March 2022 purchase own shares up to a maximum value of DKK 40 million and no more than 316,942 shares, corresponding to 1.6% of the share capital at commencement of the programme. The share buyback programme has been implemented in accordance with EU Market Abuse Regulation, EU Regulation no. 596/2014 of 16 April 2014 and the provisions

Redwood Pharma to attend the ARVO annual meeting and BIO-Europe (Fall) in 2022

Redwood Pharma will be attending two of the leading international conferences in ophthalmology and biotechology during 2022. The goals of the conferences will be to explore partnering interest in the Company’s two dry eye programs, RP501 and RP101, as well as explore development collaborations where the IntelliGel drug delivery platform can be used. · ARVO (Virtual) – May 11-12 · BIO-Europe (Fall, Leipzig Germany) – Oct. 24 – 26 To set up a meeting with Redwood Pharma, please contact:Martin Vidaeus – CEO, Phone: +46 70-232 29 29Email: martin.vidaeus@redwoodpharma.com RP501

LDA Capital Limited partially converts its convertible loan

LDA Capital Limited partially converts its convertible loan Endomines AB (publ), Stock Exchange Release 24 January 2022 at 14:00 CET   As communicated by Endomines AB (publ) ("Endomines" or the "Company") on 4 January 2022, Endomines has issued a convertible loan to LDA Capital Limited ("LDA") in a total amount of EUR 2,000,000. LDA has now notified Endomines that LDA wishes to convert part of this loan, EUR 750,000, into new shares in Endomines. The remaining amount of the convertible loan, EUR 1,250,000, may be converted at any time up to and including 5 July 2023.

Construction of the Wintteri education and well-being centre begins in Uusikaupunki

SRV GROUP PLC     INVESTOR NEWS     24 JANUARY 2022    14:30 EET Construction of the Wintteri education and well-being centre begins in Uusikaupunki SRV and the City of Uusikaupunki have signed an agreement to start up the implementation phase of the new Wintteri education and well-being centre. The project will be implemented under a lifecycle model in which SRV commits to building the property and taking care of its maintenance and upkeep for the next 20 years. The value of the contract is EUR 59.7 million and the value of the life cycle services period is EUR 28.2 million.

Campus springs to life with packed events programme

Staffordshire University is inviting the public onto campus for an exciting programme of free events this Spring.Highlights include experts talks, special events to commemorate Holocaust Memorial Day and International Women’s Day plus a week of activity to celebrate the opening of new £40m building The Catalyst. On Thursday 27 January, Staffordshire University will share a range of online resources to mark Holocaust Memorial Day. This includes videos from University Chaplain Revd. Mick Williams and Professor Caroline Sturdy Colls who will talk about the Treblinka extermination camp where

The Canadian Intellectual Property Office intends to grant RhoVac’s patent application for RV001 (onilcamotide) cancer vaccine

RhoVac AB (”RhoVac”) announces today, 24[th] January 2022, that the Canadian Intellectual Property Office (”CIPO”) has issued a “Notice of Allowance”, which means that it intends to grant RhoVac’s patent application for RV001 (onilcamotide) cancer vaccine. The company has previously been granted patents relating to onilcamotide in USA, Europe and Japan. The Canadian patent will provide RhoVac’s onilcamotide vaccine with broad protection in a key market and significantly strengthens the company’s patent portfolio.The Canadian Intellectual Property Office (”CIPO”) has communicated its

MUNTERS ACQUIRES EDPAC, A MANUFACTURER OF DATA CENTER EQUIPMENT, AND STRENGTHENS ITS PRESENCE IN EUROPE

Munters has acquired EDPAC, an Ireland-based manufacturer of data center cooling equipment and air handling systems for a purchase price of MEUR 29. The acquisition is part of Munters strategy to grow in the prioritized data center segment. Munters is a leader of energy efficient data center cooling solutions in North America and strengthens its presence in Europe through the acquisition.EDPAC reported net sales of MEUR 17 and an adjusted EBITDA of MEUR 1.7 in the financial year ending April 2021. The company is headquartered in Carrigaline, Ireland with two manufacturing facilities in the

There are no items matching the current filter
There are no more items matching the current filter
Back to top